$125 Million

Emergent BioSolutions

Buy-side

Financial Advisor, July 2017

Acquisition of ACAM2000® Business from Sanofi SA

Emergent is a specialty pharmaceutical company focused on the development of products for civilian and military populations that address emerging public health threats. The Company currently has five marketed products targeting biological and chemical threats with a pipeline of six antiviral, antibiotic and vaccine product candidates.

More Like This

Apr 2023
$55 Million

Acquisition of all assets related to the REMI Robotic Navigation System from Fusion Robotics, LLC

Exclusive Financial Advisor

View Details >
Apr 2023

Acquisition and Financing of Shapiro Aesthetic Plastic Surgery & Skin Klinic

Exclusive Financial Advisor

View Details >
Nov 2022

Inspire Aesthetics, Inc., a Portfolio Company of Hidden Harbor Capital Partners, Has Acquired McCollough Plastic Surgery Clinic

Exclusive Financial Advisor

View Details >